Friederike A.
- Country
- Germany
- Department
- -
Research Overview
- Evaluation of Safety, Tolerability, and Anti-Tumor Activity of IMA402 in Recurrent/Refractory Solid Tumors: A Phase I/II Clinical Trial
- Phase II Multicenter Study of Neoadjuvant Sacituzumab Govitecan and Zimberelimab in Resectable Non-Small Cell Lung Cancer
- A single-arm phase II-study to confirm efficacy and feasibility of tarlatamab treatment in patients with extensive stage small-cell lung cancer with poor performance status (SPACE-T) [without IMPD-Q]
Data & Insights
Has run more than one trial at 7 of 45 partner sites.
Specializations
Cardiology
Clinical research activity in cardiovascular medicine with attention to conditions affecting the heart and circulation, including diagnostic and therapeutic strategies used in internal medicine.
- Heart disease
- Vascular disorders
Work is aligned with the management of cardiac care and related treatment pathways within a hospital-based medical department.
Internal Medicine
Research involvement in internal medicine with a focus on adult patient care across complex systemic conditions, particularly where cardiovascular and general medical issues intersect.
- Adult medicine
- Complex comorbidity management
This area supports clinical innovation in the evaluation and treatment of medically complex patients within a hospital setting.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.